(1)
Anukanon, S.; Teerapatarakan, N.; Hankitichai, P. Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting MTOR and NGFR Pathways. SEJ 2026, 42, 50-70.